News
DGAP-News: SPARTA AG: Bezugsangebot veröffentlicht
DGAP-Adhoc: Sparta AG: Geänderte Prognose für die Fünfjahres-Rendite der Jahre 2015 bis 2019
Scherzer & Co. AG: Offener Brief an Vorstand und den Aufsichtsratsvorsitzenden der Lotto24 AG
Lindblad Expeditions (LIND) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
Lindblad Expeditions (NASDAQ: LIND)Q1 2024 Earnings CallApr 30, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Lindblad Expeditions (LIND) Q4 2023 Earnings Call Transcript
Image source: The Motley Fool.
Lindblad Expeditions (NASDAQ: LIND)Q4 2023 Earnings CallFeb 28, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Lindblad Expeditions (LIND) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Lindblad Expeditions (NASDAQ: LIND)Q3 2023 Earnings CallNov 02, 2023, 8:30 a.m. ET
Operator
Source Fool.com
Down 22% in the Last Month, Why Lindblad Expeditions Stock Is a Buy
Adventure travel company Lindblad Expeditions (NASDAQ: LIND) has recently benefited from surging vacation demand. After sinking to an all-time low of $3.01 at the onset of the pandemic, its stock
Lindblad Expeditions (LIND) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Lindblad Expeditions (NASDAQ: LIND)Q2 2023 Earnings CallJul 27, 2023, 8:30 a.m. ET
Operator
Source Fool.com
3 Reasons to Be Bullish on Lindblad Expeditions Stock
Expedition travel company Lindblad Expeditions (NASDAQ: LIND) has benefited from a recent wave of adventure tourism, now offering additional land-based adventures to complement its ever-evolving
Lindblad Expeditions Hits All-Time Highs in Revenue and Earnings. Time to Buy the Stock?
First-quarter earnings for Lindblad Expeditions (NASDAQ: LIND) landed all-time highs in both revenue and earnings before interest, taxes, depreciation, and amortization (EBITDA). While resurgent
Lindblad Expeditions (LIND) Q1 2023 Earnings Call Transcript
Image source: The Motley Fool.
Lindblad Expeditions (NASDAQ: LIND)Q1 2023 Earnings CallMay 03, 2023, 8:30 a.m. ET
Operator
Source Fool.com
Edison issues review on Tetragon Financial Group (TFG): FY23 growth driven by idiosyncratic factors
Edison issues re-initiation on Heliad (A7A): Starting a new chapter
Update on the Scheme and Publication of Notice of Second General Meeting
Financial update on Harpoon Therapeutics acquisition by Merck (MSD)
Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)